Open Access
Open access

Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player

MONICA NEAGU 1, 2, 3
Carolina Constantin 1, 3
Iulia Dana Popescu 4
Donato Zipeto 5
George Tzanakakis 6
Dragana Nikitovic 6
Concettina Fenga 7
Constantine A. Stratakis 8
Demetrios A Spandidos 9
Aristidis M Tsatsakis 10
Publication typeJournal Article
Publication date2019-05-14
scimago Q2
wos Q2
SJR1.075
CiteScore6.9
Impact factor3.3
ISSN2234943X
Cancer Research
Oncology
Abstract
Cancer metabolism is an essential aspect of tumorigenesis, as cancer cells have increased energy requirements in comparison to normal cells. Thus, an enhanced metabolism is needed in order to accommodate tumor the cells’ accelerated biological functions, including increased proliferation, vigorous migration during metastasis and adaptation to tissues different from the primary invasion site. In this context, the assessment of tumor cell metabolic pathways generates crucial data pertaining to the mechanisms through which tumor cells survive and grow in a milieu of host defense mechanisms. Indeed, various studies have demonstrated that the metabolic signature of tumors is heterogeneous. Furthermore, these metabolic changes induce the exacerbated production of several molecules, which result in alterations that aid an inflammatory milieu. The therapeutic armentarium for oncology should thus include metabolic and inflammation regulators. Our expanding knowledge of the metabolic behavior of tumor cells whether from solid tumors or hematologic malignancies, may provide the basis for the development of tailor-made cancer therapies.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
8
International Journal of Molecular Sciences
8 publications, 6.35%
Frontiers in Oncology
5 publications, 3.97%
Antioxidants
4 publications, 3.17%
Journal of Immunology Research
3 publications, 2.38%
Journal of Translational Medicine
2 publications, 1.59%
Molecules
2 publications, 1.59%
Cancers
2 publications, 1.59%
Frontiers in Immunology
2 publications, 1.59%
Food and Chemical Toxicology
2 publications, 1.59%
Cancer Letters
2 publications, 1.59%
FASEB Journal
2 publications, 1.59%
Advances in Experimental Medicine and Biology
2 publications, 1.59%
Interdisciplinary Cancer Research
2 publications, 1.59%
Food Frontiers
2 publications, 1.59%
Life
1 publication, 0.79%
Aging
1 publication, 0.79%
Experimental and Therapeutic Medicine
1 publication, 0.79%
Advances in Pharmacological and Pharmaceutical Sciences
1 publication, 0.79%
Cells
1 publication, 0.79%
Nutrients
1 publication, 0.79%
Journal of Clinical Medicine
1 publication, 0.79%
Biomolecules
1 publication, 0.79%
Pharmaceutics
1 publication, 0.79%
Biomedicines
1 publication, 0.79%
Antibiotics
1 publication, 0.79%
Frontiers in Cell and Developmental Biology
1 publication, 0.79%
Frontiers in Physiology
1 publication, 0.79%
Frontiers in Psychiatry
1 publication, 0.79%
Pharmaceuticals
1 publication, 0.79%
1
2
3
4
5
6
7
8

Publishers

5
10
15
20
25
30
MDPI
28 publications, 22.22%
Elsevier
24 publications, 19.05%
Springer Nature
19 publications, 15.08%
Frontiers Media S.A.
11 publications, 8.73%
Wiley
7 publications, 5.56%
Hindawi Limited
5 publications, 3.97%
Spandidos Publications
4 publications, 3.17%
Cold Spring Harbor Laboratory
4 publications, 3.17%
Taylor & Francis
3 publications, 2.38%
American Chemical Society (ACS)
3 publications, 2.38%
Public Library of Science (PLoS)
2 publications, 1.59%
Federation of American Societies for Experimental Biology (FASEB)
2 publications, 1.59%
Bentham Science Publishers Ltd.
2 publications, 1.59%
Royal Society of Chemistry (RSC)
2 publications, 1.59%
Impact Journals
1 publication, 0.79%
IGI Global
1 publication, 0.79%
American Society for Microbiology
1 publication, 0.79%
AME Publishing Company
1 publication, 0.79%
AIP Publishing
1 publication, 0.79%
5
10
15
20
25
30
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
126
Share
Cite this
GOST |
Cite this
GOST Copy
NEAGU M. et al. Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player // Frontiers in Oncology. 2019. Vol. 9.
GOST all authors (up to 50) Copy
NEAGU M., Constantin C., Popescu I. D., Zipeto D., Tzanakakis G., Nikitovic D., Fenga C., Stratakis C. A., Spandidos D. A., Tsatsakis A. M. Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player // Frontiers in Oncology. 2019. Vol. 9.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3389/fonc.2019.00348
UR - https://doi.org/10.3389/fonc.2019.00348
TI - Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player
T2 - Frontiers in Oncology
AU - NEAGU, MONICA
AU - Constantin, Carolina
AU - Popescu, Iulia Dana
AU - Zipeto, Donato
AU - Tzanakakis, George
AU - Nikitovic, Dragana
AU - Fenga, Concettina
AU - Stratakis, Constantine A.
AU - Spandidos, Demetrios A
AU - Tsatsakis, Aristidis M
PY - 2019
DA - 2019/05/14
PB - Frontiers Media S.A.
VL - 9
PMID - 31139559
SN - 2234-943X
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2019_NEAGU,
author = {MONICA NEAGU and Carolina Constantin and Iulia Dana Popescu and Donato Zipeto and George Tzanakakis and Dragana Nikitovic and Concettina Fenga and Constantine A. Stratakis and Demetrios A Spandidos and Aristidis M Tsatsakis},
title = {Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player},
journal = {Frontiers in Oncology},
year = {2019},
volume = {9},
publisher = {Frontiers Media S.A.},
month = {may},
url = {https://doi.org/10.3389/fonc.2019.00348},
doi = {10.3389/fonc.2019.00348}
}